Metabolic Syndrome and Periodontal Disease Interrelationships

Metabolic syndrome describes a cluster of interrelated risk factors—central obesity, dyslipidaemia, hypertension and insulin resistance—that collectively heighten the likelihood of cardiovascular disease and type 2 diabetes. Periodontal disease, encompassing gingivitis and its progressive form periodontitis, is a chronic inflammatory condition in which microbial dysbiosis and host immune responses drive destruction of the supporting structures of teeth. Emerging evidence reveals a bidirectional link: systemic inflammation and metabolic disturbances characteristic of metabolic syndrome can exacerbate periodontal breakdown, while untreated periodontitis contributes to systemic inflammatory burden, endothelial dysfunction and impaired glycaemic control. Key mediators include adipokines and pro-inflammatory cytokines, oxidative stress and shifts in the oral microbiome that extend beyond local tissues. Gender differences have been observed, with some studies indicating stronger associations of metabolic components with periodontal inflammation in women. The global significance is underscored by the parallel rise in obesity and diabetes and the high prevalence of periodontitis across diverse populations. Integrated patient care models that combine metabolic risk screening in dental clinics and periodontal assessment in medical settings hold promise for early intervention, tailored treatment planning and mitigation of long-term cardiovascular and metabolic complications.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Metabolic Syndrome and Periodontal Disease Interrelationships publication trend

The graph below shows the total number of articles in metabolic syndrome and periodontal disease interrelationships across all publications each year (not limited to Nature Index journals).

Technical terms

Metabolic syndrome: A constellation of metabolic abnormalities—central adiposity, insulin resistance, dyslipidaemia and hypertension—that increases cardiovascular and diabetic risk.

Periodontitis: A progressive inflammatory disease of the periodontium characterised by loss of connective tissue attachment and alveolar bone leading to tooth mobility.

Insulin resistance: A pathophysiological state in which target tissues fail to respond adequately to circulating insulin, driving compensatory hyperinsulinaemia.

Adipokine: Bioactive peptides secreted by adipose tissue that regulate inflammation, metabolism and immune function.

Oxidative stress: An imbalance between reactive oxygen species production and antioxidant defences, contributing to cellular and tissue damage.

Dysbiosis: A disturbance in the normal microbial community structure, leading to pathogenic overgrowth and altered host–microbial interactions.

References

1. Association between metabolic syndrome components and gingival bleeding is women-specific: a nested cross-sectional study. Journal of Translational Medicine (2023).
2. Periodontal Disease and Its Association with Metabolic Syndrome—A Comprehensive Review. International Journal of Molecular Sciences (2023).
3. Association between metabolic syndrome and periodontitis: The role of lipids, inflammatory cytokines, altered host response, and the microbiome. Periodontology 2000 (2021).